Abstract

Longitudinal monitoring of liver function in vivo is hindered by the lack of high-resolution non-invasive imaging techniques. Using the anterior chamber of the mouse eye as a transplantation site, we have established a platform for longitudinal in vivo imaging of liver spheroids at cellular resolution. Transplanted liver spheroids engraft on the iris, become vascularized and innervated, retain hepatocyte-specific and liver-like features and can be studied by in vivo confocal microscopy. Employing fluorescent probes administered intravenously or spheroids formed from reporter mice, we showcase the potential use of this platform for monitoring hepatocyte cell cycle activity, bile secretion and lipoprotein uptake. Moreover, we show that hepatic lipid accumulation during diet-induced hepatosteatosis is mirrored in intraocular in vivo grafts. Here, we show a new technology which provides a crucial and unique tool to study liver physiology and disease progression in pre-clinical and basic research.

Longitudinal monitoring of liver function in vivo is hindered by the lack of high-resolution non-invasive imaging techniques. Here, the authors show a crucial and unique tool for longitudinal in vivo imaging of liver spheroids at cellular resolution to study liver physiology and disease.

Details

Title
Intraocular liver spheroids for non-invasive high-resolution in vivo monitoring of liver cell function
Author
Lazzeri-Barcelo, Francesca 1 ; Oliva-Vilarnau, Nuria 2 ; Baniol, Marion 3 ; Leibiger, Barbara 1 ; Bergmann, Olaf 4   VIAFID ORCID Logo  ; Lauschke, Volker M. 5   VIAFID ORCID Logo  ; Leibiger, Ingo B. 1 ; Moruzzi, Noah 1   VIAFID ORCID Logo  ; Berggren, Per-Olof 6 

 Karolinska Institutet, The Rolf Luft Research Center for Diabetes and Endocrinology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
 Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); TU Dresden, Center for Regenerative Therapies Dresden, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257); University Medical Center Goettingen, Department of Pharmacology and Toxicology, Goettingen, Germany (GRID:grid.411984.1) (ISNI:0000 0001 0482 5331) 
 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany (GRID:grid.502798.1) (ISNI:0000 0004 0561 903X); University of Tübingen, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447) 
 Karolinska Institutet, The Rolf Luft Research Center for Diabetes and Endocrinology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Tecnológico de Monterrey, Monterrey, Mexico (GRID:grid.419886.a) (ISNI:0000 0001 2203 4701); University of Miami. Miller School of Medicine, Diabetes Research Institute, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606) 
Pages
767
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2918730129
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.